A recent study published in Current Molecular Pharmacology reveals that three long non-coding RNAs—HEIH, MIAT, and HOTAIR—are significantly upregulated in Egyptian non-metastatic hepatocellular ...
While new late-stage data point to some liver toxicity signals, analysts at BMO Capital Markets said Tukysa’s efficacy ...
The liver often shows subtle warning signs before serious disease develops. Persistent right-sided pain, itchy skin, ...
The FDA approved Akeega combination therapy for adults with BRCA2-mutated metastatic castration-sensitive prostate cancer.
Tukysa added to Herceptin and Perjeta improved progression-free survival versus placebo in HER2-positive metastatic breast ...
4don MSN
Pancreatic cancer cells 'speak the language' of organs they will later invade, study reveals
Even as they develop at their primary site, pancreatic cancer cells are already expressing the genes that will determine ...
My best advice for anyone recently diagnosed with MBC is to keep a notebook and take someone with you to every appointment.
“Cancer cells from patient’s primary tumours that ended up relapsing in the liver or the lung early on adopt cellular states ...
Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new ...
Progression-free response stayed consistent across age, BMI, and menopausal status in MONALEESA pooled analysis1 KISQALI is only CDK4/6i to demonstrate statistically significant overall survival (OS) ...
Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback